This one is a conversation rather than a lecture. Tony Huge’s guest, Steven, describes what happened when he tried PT-141 after years of relying on PDE5 pills, and the difference he noticed was not the erection. It was the arousal. Tony fills in the mechanism: PDE5 inhibitors work on blood flow, PT-141 works on desire, and the two are not the same lever. Along the way they cover the flush, the oxytocin pairing, how Tony found the compound through a tanning peptide almost two decades ago, and why he insists the first step for anyone is the smallest, safest one.
Video: The Peptide That Brings Back Your Libido at Any Age. Published May 15, 2026. Watch on YouTube.
What the video covers
- 00:00 Steven’s verdict: “I felt aroused constantly” and why he says the future is here.
- 00:48 Supplements versus the gym: Tony’s prediction that the visible divide will be who takes the right supplements, not who trains.
- 01:35 Mass blast and cruise: Compressing six months into two weeks, then holding a low-maintenance physique.
- 02:27 Is it too late to start? Tony’s answer about technology and adaptation.
- 03:21 Start safe: Why a bad first experience makes people swear off everything.
- 04:03 PT-141 versus PDE5 pills: Flushing, headaches and heartburn on one side; a brief flush and lasting arousal on the other.
- 05:39 How Tony found it: Melanotan for tanning about 17 years ago, and the side effect that became the point.
- 06:48 Self-experimentation: Why thousands of compounds get no attention until someone tries them and reports.
- 07:13 The oxytocin pairing: Which compound does what in the combination.
- 08:11 Dose direction: Why the answer to too much of a side effect is less.
- 08:55 Hair transplant aside: Tony’s honest read on Steven’s hairline.
Two different levers
Steven’s experience with PDE5 inhibitors is the familiar one: he gets massively flushed, sometimes bad heartburn and headaches, and afterward is left with an erection that outlasts any interest in it. His experience with PT-141 was a brief flush at the start that then cleared, and then, in his words, hours of arousal rather than hours of mechanical hardness. What he noticed most was that the desire stayed, that he felt aroused in between, and that some of that enthusiasm carried into days when he had taken nothing.
Tony’s explanation is the useful part. PDE5 inhibitors are blood flow drugs. They act on the vasculature, which is why the side effects are vascular: the face flushes, the head aches, the blood goes everywhere including places you did not ask for. PT-141 is a melanocortin agonist acting centrally, on libido itself. It does not push blood anywhere. That distinction is why one leaves a man with a hard-on and no interest, and the other leaves him interested. It is also why Tony frames them as separate tools rather than competitors, and why his answer to too much blood flow on the pill side is not a different drug but a lower dose.
How a tanning peptide became a libido peptide
Tony’s route to PT-141 was accidental. Around 17 years ago he used Melanotan to darken his skin. It worked, and it also made him, as he puts it, really horny. So he used it for that too. PT-141 arrived later as the version for people who wanted the sexual effect without the tan, and he estimates he has been experimenting with it for around 15 years. He is careful to say it is not his product and not his invention. These compounds are engineered by companies that want to develop and sell them. What he does is get them early, self-experiment, report the benefits and the side effects, and give other people enough information to feel comfortable trying.
“There’s thousands of medications out there that don’t get attention until someone self-experiments.”
Tony Huge, 06:48
The pairing
Steven had combined PT-141 with a second compound and wanted to know which did what. Tony’s answer: the oxytocin makes you more mellow, and the PT-141 is the libido. In Steven’s account the combination is why it was not just sitting there with an erection; there was warmth and connection alongside the drive. Tony’s principle for both is the same one he applies to the PDE5 side. If you find the right dose of each, they work together. If a side effect shows up, the move is down, not off. He is explicit about the failure mode he is trying to prevent: someone takes too much of something, has a bad reaction, and concludes they do not like supplements. He gives retatrutide and the GLP-1s as the same lesson. People inject, get nauseous, swear it off, when the answer was a lower starting point.
Is it too late to start?
Steven asks whether he has missed the boat on biohacking the way people feel they missed early cryptocurrency. Tony’s comparison is the smartphone. People who grew up without them adapted, maybe not as fast as kids raised with them, but adapted. This is a technology, and it is going to keep evolving, so the sooner you build a foundation of knowledge and comfort, the better positioned you are for what comes next. His prediction for the visible future is blunt: the divide on the street will not be who goes to the gym and who does not. It will be who takes the right supplements and who does not, and Steven, who Tony jokes he has never seen in a gym, is his exhibit.
Tony also sketches the mass blast idea in passing: build as much muscle as possible in a short window, then cruise on a low-maintenance physique. It is more expensive up front because it compresses roughly six months of supplementation into two weeks, and then it is quiet. The economic framing Steven offers back is that a few hundred dollars a month is less than some people pay per week for other approaches, and far less than surgery.
Cheat Sheet Pivot
What Steven reported and what Tony described, not instructions for anyone else.
- Steven’s report: a brief initial flush on PT-141, then hours of arousal without the headache, heartburn or lingering erection he got from PDE5 pills.
- Tony’s mechanism: PDE5 inhibitors act on blood flow; PT-141 acts on libido; oxytocin, in the pairing Steven used, adds a mellow, connected quality rather than drive.
- Tony found the effect through Melanotan around 17 years ago and has experimented with PT-141 for roughly 15 years.
- His rule for side effects on any of these is to reduce the dose rather than abandon the compound, so a bad first experience does not close the door.
- He recommends beginning with something simple and safe to build comfort before anything more involved.
PT-141 and its relatives are in the Miracle Molecules Cheat Sheet. For the mechanism in more depth, read PT-141 (Bremelanotide): The Honest Truth About the Libido Peptide, and for why Tony argues less is more with this compound, see PT-141 (Bremelanotide) Guide: The Low-Dose Protocol That Actually Works.
Where the evidence stops
This is a two-person conversation, and neither man cites a study. Steven’s account is one person’s experience, on a compound he borrowed rather than dosed by any protocol, combined with a second compound, so nothing in it isolates PT-141’s effect. Tony’s mechanism distinction between vascular and central action is a fair description of how the two drug classes are understood to work, but the video does not present trial data on efficacy, side effect rates or the oxytocin pairing. The claim that the arousal carried over into untreated days is Steven’s impression, not a measured effect. The video makes no claim about safety in any specific population and both men repeatedly say to start low.
Keep going
For the second half of the pairing, read Oxytocin and Longevity: Can the Love Hormone Actually Slow Aging?. Companion articles go out first to the tonyhuge.is email list, and the peptide archive is on tonyhuge.is.